Increased extra domain-A containing fibronectin and hepatic dysfunction during septic response:: an in vivo and in vitro study

被引:10
作者
Satoi, S
Kitade, H
Hiramatsu, Y
Kwon, AH
Takahashi, H
Sekiguchi, K
Uehara, M
Oda, M
Yanagimoto, Y
Miyashita, K
Sakashita, E
Kamiyama, Y
机构
[1] Kansai Med Univ, Dept Surg 1, Osaka 5708507, Japan
[2] Kansai Med Univ, Dept Clin Sci & Lab Med, Osaka 5708507, Japan
[3] Osaka Univ, Inst Prot Res, Osaka, Japan
[4] Otsuka Pharmaceut Co Ltd, Tokushima 77101, Japan
来源
SHOCK | 2000年 / 13卷 / 06期
关键词
hepatocyte; fibroblast; sepsis; culture; cytokine; interleukin-1; tumor necrosis factor-alpha; interleukin-6;
D O I
10.1097/00024382-200006000-00012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A massive inflammatory reaction resulting from systemic cytokine release is the common pathway underlying sepsis or multiple organ dysfunction. The role of extra domain sequence A-containing fibronectin (EDA+FN) formation during the septic response is not known. The present study investigates the role of EDA+FN during the septic response under in vitro and in vivo conditions. The direct effects of interleukin-1, interleukin-6, and tumor necrosis factor-alpha on EDA+FN production were evaluated in primary cultured human hepatocytes and fibroblasts. Serial plasma EDA+FN levels were measured using an enzyme-linked immunosorbent assay in 24 patients who developed postoperative sepsis following general abdominal surgery of which there were 17 survivors and 7 non-survivors. EDA+FN secretion was significantly increased in cultured hepatocytes but not fibroblasts at 24 and 48 h following exposure to IL-1 compared to controls. In the clinical setting plasma EDA+FN levels in non-survivors were significantly higher than in survivors. Moreover, the EDA+FN levels were correlated closely with liver function tests. EDA+FN levels may represent a specific marker of vascular injury or systemic inflammatory response syndrome that is associated with an adverse clinical outcome.
引用
收藏
页码:492 / 496
页数:5
相关论文
共 28 条
[11]   RESPONSE OF FIBRONECTIN TO LIVER-REGENERATION AFTER HEPATECTOMY [J].
KWON, AH ;
INADA, Y ;
UETSUJI, S ;
YAMAMURA, M ;
HIOKI, K ;
YAMAMOTO, M .
HEPATOLOGY, 1990, 11 (04) :593-598
[12]  
KWON AH, 1990, ANN SURG, V211, P295
[13]   FETAL FIBRONECTIN IN CERVICAL AND VAGINAL SECRETIONS AS A PREDICTOR OF PRETERM DELIVERY [J].
LOCKWOOD, CJ ;
SENYEI, AE ;
DISCHE, MR ;
CASAL, D ;
SHAH, KD ;
THUNG, SN ;
JONES, L ;
DELIGDISCH, L ;
GARITE, TJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) :669-674
[14]  
MCDONALD JA, 1980, J BIOL CHEM, V255, P8848
[15]  
MCKEOWNLONGO PJ, 1984, J BIOL CHEM, V259, P2210
[16]   DEGRADATION OF PROSTAGLANDIN-E2 IN A PRIMARY CULTURE OF ADULT-RAT HEPATOCYTES [J].
OKUMURA, T ;
SAITO, K .
JOURNAL OF BIOCHEMISTRY, 1984, 96 (02) :429-436
[17]  
PETERS JH, 1989, J LAB CLIN MED, V113, P586
[18]   INTRAVASCULAR RELEASE OF INTACT CELLULAR FIBRONECTIN DURING OXIDANT-INDUCED INJURY OF THE INVITRO PERFUSED RABBIT LUNG [J].
PETERS, JH ;
GINSBERG, MH ;
BOHL, BP ;
SKLAR, LA ;
COCHRANE, CG .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1596-1603
[19]   MATRIX FIBRONECTIN DISRUPTION IN ASSOCIATION WITH ALTERED ENDOTHELIAL-CELL ADHESION INDUCED BY ACTIVATED POLYMORPHONUCLEAR LEUKOCYTES [J].
RICHARDS, PS ;
SABA, TM ;
DELVECCHIO, PJ ;
VINCENT, PA ;
GRAY, VC .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1986, 45 (01) :1-21
[20]  
RICK TA, 1994, AM JPHYSL, V266, P689